Global Pharmaceutical Cartridges Market Size, Share, Opportunities, And Trends By Material (Glass, Plastic), By Cartridge Size (Less than 3 ml, 3ml to 5ml, 5ml to 10ml, Greater than 10ml), By End-User (Pharmaceutical Company, Biotech Company, Biomedical Research Organization), And By Geography- Forecasts From 2025 To 2030

The global pharmaceutical cartridge market is expected to grow at a CAGR of 3.23% over the forecast period to reach a total market size of US$3.265 billion by 2030, increasing from US$2.785 billion in 2025.

The pharmaceutical packaging cartridge market holds strong growth prospects in the forecast period due to the growing demand for effective packaging solutions for preventing drug contamination. Thus, the growing pharmaceutical packaging industry is fueling the market expansion. The increasing prevalence of chronic disease is driving market growth in the forecast period. With growing diabetes globally, insulin delivery systems using pre-fillable syringes are further augmenting the demand. The growing geriatric population, accompanied by age-associated diseases, is further propelling the market expansion in the forecast period. Moreover, cartridges form an important part of many drug delivery systems. Hence, the market is poised to grow significantly with the growing drug delivery industry. With the growing biomedical and biotech research worldwide, the use of cartridges is immense in biotech companies and biomedical research organizations apart from pharmaceutical organizations. Hence, these are further providing an opportunity for the market to thrive in the forecast period.

Geographically, the USA in the North American region is estimated to hold a significant market share with high expenditure and a well-established pharmaceutical industry. On the other hand, Asia Pacific is projected to grow with a high CAGR, especially in the developing economies of India and China, owing to the high prevalence of people suffering from chronic diseases like diabetes and insulin dependence.

What are the drivers of the global pharmaceutical cartridge market?

• The prevalence of insulin-dependent diabetes, type 1 and type 2, is augmenting the market demand in the forecast period.

The increasing de  According to the American Diabetes Association (ADA), the prevalence of individuals with type 1 diabetes where the pancreas is not capable of producing insulin is prevalent. More than one million Americans have this disease. Type 2 diabetes is the most common form of diabetes found in the United States; according to the CDC, more than 90% of individuals are diagnosed with this disease. However, not everyone is recommended for insulin injections. In 2023, 38 million Americans were affected by diabetes, and around 5%-10% of Americans were found to have type 1 diabetes. Hence, with the high disease prevalence, the market for insulin cartridges holds strong growth prospects in the United States and other parts of the world.

According to the WHO, in 2022, about 830 million people were having diabetes globally. Furthermore, the common consequences of diabetes include damage to the heart, blood vessels, kidneys, eyes, and nerves. Individuals suffering from diabetes are at an increased risk of heart attacks and strokes. With reduced blood flow, there are high chances of nerve damage in the feet, which raises the chances of foot ulcers and infection, resulting in limb amputation. Diabetic retinopathy plays an important role in causing blindness due to damage to small blood vessels in the retina. It is estimated that this contributes to around 2% of blindness at the global level. Hence, effective measures are taken for early disease diagnosis and prevention. In the case of severe diabetes requiring insulin drug delivery, the market will grow significantly in the forecast period.

As per the International Diabetes Federation (IDF) Statistics, at present, every 7 seconds, a person is estimated to die from diabetes or diabetes-related complications, accounting for around 4 million deaths every year. Around half of all deaths are attributed to people under the age of 60. The prevalence is estimated to increase to 9.9% by 2045. It is projected to surge to 628.6 million individuals by the end of 2045.

• The presence of companies offering varied products of different capacities as per the customers’ demand is driving the market growth in the forecast period.

Various drug delivery devices that make use of multi-use pens or pen injectors demand cartridge technology for safe drug storage and also hold suitability for high-viscosity drugs under various storage conditions.

West Pharmaceutical Services Daikyo Crystal Zenith cartridges provide superior, predictable functionality, safety, and compatibility with varied devices. This comprises a crystal zenith polymer. These cartridges have superior barrier protection, superior functional performance without silicone oil, compatibility with high-viscosity drugs, tight dimensional tolerances, and suitability for auto-injectors and pen-delivery systems. The company’s SmartDose® Generation I drug delivery platform, approved by the US FDA, offers a wearable subcutaneous injector with an integrated drug delivery system for delivering a truly patient-centric approach to self-administration. The device is capable of being user-loaded, and subcutaneous self-administration is capable of introducing high volume and high viscosity drug products that are connectivity capable and easy and convenient to operate.

SCHOTT AG offers a broad range of containers, quality levels, and controlled surface chemistry to fulfill the customized needs of primary packaging. These also comply with PH. Eur., USP, and JP international standards. Schott cartridges are manufactured based on advanced production lines containing highly stable and validated processes. Permanent process optimization is achieved through Six Sigma principles and the professional training provided to the employees, maintaining the quality to the highest levels. The cartridge handling is continuously optimized to decrease glass-to-glass contact, thereby leading to an increase in mechanical strength and exceptional cosmetic quality.

Gerresheimer cartridges are high-quality, with fill volumes ranging from 1.5 ml to 3.0 ml. Up to 10 ml can be manufactured as per the customer’s need for various pharma applications. The product range consists of clear and amber cartridges made of borosilicate glass of hydrolytic class I. There are options for ammonium sulfate treatment for enhanced surface resistance. The company manufactures cartridges for dental applications and cartridges for pen drug delivery systems.

What are the key geographical trends shaping the global pharmaceutical cartridge market?

By geography, the global pharmaceutical cartridge market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries.

The Asia Pacific region is expected to see notable growth in the global pharmaceutical cartridge market, boosted by the healthcare sector. According to the India Brand Equity Foundation (IBEF), the Indian Healthcare industry continued its healthy growth in 2023, reaching US$372 billion, driven by both the private sector and the government.

Key developments in the global pharmaceutical cartridge market:

The major leaders of the global pharmaceutical cartridge market are Gerresheimer AG, Stevanato Group, SCHOTT AG, West Pharmaceutical Services, Inc., Transcoject GmbH, Sigma-Aldrich, Inc., Nipro Corporation, Dätwyler Holding Inc., and Shandong Province Medicinal Glass Co., Ltd. The key players in the market implement growth strategies such as product launches, mergers, acquisitions, etc., to gain a competitive advantage. For Instance,

• In September 2024, SCHOTT Pharma AG & Co. KGaA, together with Gerresheimer AG and Stevanato Group S.p.A., entered into a strategic industry alliance to support market adoption of Ready-to-Use (RTU) vials and cartridges.
• In February 2024, Orion Engineered Carbons, a s INCOG BioPharma Services, added a high-speed OPTIMA filling line that will provide an additional 100 million units of syringe and cartridge filling capacity. This second filling line will be delivered on-site this summer and will qualify for GMP production in Q2 of 2025. It would bring the company's total filling capacity to 140 million units per year.
• In March 2022, The first generic version of APOKYN® Cartridges, apomorphine hydrochloride cartridges, 30 mg/3 mL, was approved and launched in March 2022 by TruPharma, LLC and its development and business partner Sage Chemical, Inc.
• In May 2022, the international technology company SCHOTT announced that it would greatly increase the number of ready-to-use (RTU) cartridges it could produce. With the use of wearable technology or pen injectors, this drug containment & delivery solution is being used to store as well as dispense medications.

Global Pharmaceutical Cartridge Market Scope:

Report Metric	Details
Pharmaceutical Cartridges Market Size in 2025	US$2.785 billion
Pharmaceutical Cartridges Market Size in 2030	US$3.265 billion
Growth Rate	CAGR of 3.23%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Material Cartridge Size End User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Pharmaceutical Cartridges Market	Gerresheimer AG Stevanato Group SCHOTT AG West Pharmaceutical Services, Inc. Transcoject GmbH
Customization Scope	Free report customization with purchase

Global Pharmaceutical Cartridge Market is analyzed into the following segments:

• By Material
  • Glass
  • Plastic
• By Cartridge Size
  • Less than 3ml
  • 3ml to 5ml
  • 5ml to 10ml
  • Greater than 10ml
• By End User
  • Pharmaceutical Company
  • Biotech Company
  • Biomedical Research Organization
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East and Africa
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Rest of Asia-Pacific

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

2.3. Data Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4.  Industry Value Chain Analysis

5. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY MATERIAL

5.1. Introduction

5.2. Glass

5.3. Plastic

6. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY CARTRIDGE SIZE

6.1. Introduction

6.2. Less than 3ml

6.3. 3ml to 5ml

6.4. 5ml to 10ml

6.5. Greater than 10ml

7. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY END-USER

7.1. Introduction

7.2. Pharmaceutical Company

7.3. Biotech Company

7.4. Biomedical Research Organization

8. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY GEOGRAPHY

8.1. Global Overview

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Rest of South America

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Rest of Europe

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. United Arab Emirates

8.5.3. Rest of the Middle East and Africa

8.6. Asia-Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Gerresheimer AG

10.2. Stevanato Group

10.3. SCHOTT AG

10.4. West Pharmaceutical Services, Inc.

10.5. Transcoject GmbH

10.6. Sigma-Aldrich, Inc.

10.7. Nipro Corporation

10.8. Dätwyler Holding Inc.

10.9. Shandong Province Medicinal Glass Co., Ltd.

Gerresheimer AG

Stevanato Group

SCHOTT AG

West Pharmaceutical Services, Inc.

Transcoject GmbH

Sigma-Aldrich, Inc.

Nipro Corporation

Dätwyler Holding Inc.

Shandong Province Medicinal Glass Co., Ltd.